Back to Search
Start Over
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study
- Source :
- Ingrasciotta , Y , Giorgianni , F , Marcian , I , Bolcato , J , Pirolo , R , Chinellato , A , Ientile , V , Santoro , D , Genazzani , A A , Alibrandi , A , Fontana , A , Caputi , AP & Trifiro , G 2016 , ' Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study ' , PLoS One (print) , vol. 11 , no. 5 , e0155805 .
- Publication Year :
- 2016
Details
- Database :
- OAIster
- Journal :
- Ingrasciotta , Y , Giorgianni , F , Marcian , I , Bolcato , J , Pirolo , R , Chinellato , A , Ientile , V , Santoro , D , Genazzani , A A , Alibrandi , A , Fontana , A , Caputi , AP & Trifiro , G 2016 , ' Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study ' , PLoS One (print) , vol. 11 , no. 5 , e0155805 .
- Notes :
- application/pdf, und
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1313620931
- Document Type :
- Electronic Resource